Company news
Telix Pharmaceuticals Limited news in 2020
Telix Pharmaceuticals Limited's news releases, calls and decks from 2020, newest first.
New Drug Submission filed with Health Canada for TLX591-CDx
December 15, 2020
IP Agreement with U Southampton for access to TRALA data
December 13, 2020
Telix Completes Acquisition of TheraPharm GmbH
December 13, 2020
FDA New Drug Application for TLX591-CDx Proceeds to Review
December 8, 2020
TGA Priority Review Granted for Prostate Cancer Imaging
December 7, 2020
ProstACT Phase III Study Clinical Development Update
December 2, 2020
Telix and DuChemBio - South Korea Partnership
December 2, 2020
Briefing for Investor call - TheraPharm GmbH Acquisition
November 30, 2020
Acquisition of TheraPharm GmbH - Investor Call
November 29, 2020
Telix Acquires TheraPharm GmbH
November 29, 2020
Prostate Cancer Therapy FDA Meeting Update
November 24, 2020
NDA for Prostate Cancer Imaging accepted by US FDA
November 23, 2020
Investor Briefing - Asia Strategy
November 2, 2020
Strategic Licence and Partnership for Greater China Market
November 1, 2020
App 4C and Activities Report for September 2020 Quarter
October 29, 2020
FDA grants Orphan Drug Designation for glioma imaging agent
October 5, 2020
Telix submits NDA to US FDA for Prostate Cancer Imaging
September 23, 2020
Strategic Collaboration with Varian for Prostate Imaging
September 2, 2020
IRE Distribution Partnership for Prostate Cancer Imaging
August 31, 2020
FDA grants orphan drug designation for TLX102
August 30, 2020
Report for half-year to 30 June 2020
August 20, 2020
Appendix 4C and Activities Report - June 2020 quarter
July 26, 2020
Receipt of $11.4M R&D tax rebate
July 21, 2020
FDA grants breakthrough designation for TLX250-CDx product
June 30, 2020
S&P DJI Announces June 2020 Quarterly Rebalance
June 11, 2020
Appendix 4C and Activity Report March 2020 quarter
April 20, 2020
Commercial Distribution Agmt for Prostate Cancer Diagnostic
April 8, 2020
Telix completes acquisition of licensed production facility
April 2, 2020
Telix and partners receive 500k CRC research grant
March 15, 2020
Positive FDA feedback on NDA submission process
February 24, 2020
Appendix 4E - Summary of Results
February 23, 2020
Appendix 4C - December 2019 Quarter
January 28, 2020
Telix Granted FDA Approval for ZIRCON Renal Cancer Imaging
January 22, 2020
Decks in 2020
- Technical Presentation (December 2020)
Technical · 13 slides · Dec 2, 2020
- Investor Presentation (November 2020)
Investor deck · 15 slides · Nov 3, 2020
- Jefferies Healthcare Conference 2020
Conference · 21 slides · Jun 4, 2020